Generation Bio Co. (GBIO)
NASDAQ: GBIO · IEX Real-Time Price · USD
2.960
-0.130 (-4.21%)
At close: Mar 18, 2024, 4:00 PM
2.890
-0.070 (-2.36%)
After-hours: Mar 18, 2024, 5:39 PM EDT

Generation Bio Co. Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
5.900000.04
Gross Profit
5.900000.04
Selling, General & Admin
50.8544.4633.8522.5812.179.18
Research & Development
93.6296.7285.2558.5350.1328.15
Operating Expenses
144.47141.18119.181.1162.337.33
Operating Income
-138.56-141.18-119.1-81.11-62.3-37.29
Other Expense / Income
-11.95-4.540.05-0.59-0.99-1.49
Pretax Income
-126.61-136.64-119.15-80.52-61.32-35.8
Net Income
-126.61-136.64-119.15-80.52-61.32-35.8
Shares Outstanding (Basic)
6458562753
Shares Outstanding (Diluted)
6458562753
Shares Change
10.96%3.23%106.54%476.06%41.22%-
EPS (Basic)
-1.96-2.35-2.12-2.95-12.96-10.69
EPS (Diluted)
-1.96-2.35-2.12-2.95-12.96-10.69
Free Cash Flow
-60.14-111.25-97.67-75.66-60.25-31.14
Free Cash Flow Per Share
-0.93-1.91-1.74-2.78-12.73-9.29
Gross Margin
100.00%----100.00%
Operating Margin
-2346.93%-----103594.44%
Profit Margin
-2144.51%-----99452.78%
Free Cash Flow Margin
-1018.67%-----86500.00%
EBITDA
-121.35-131.51-114.62-77.09-59.45-35.46
EBITDA Margin
-2055.37%-----98488.89%
Depreciation & Amortization
5.265.134.533.431.860.35
EBIT
-126.61-136.64-119.15-80.52-61.32-35.8
EBIT Margin
-2144.51%-----99452.78%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).